Fadogia Agrestis is the more speculative half of the famous “natural testosterone” stack — the one usually mentioned in the same breath as Tongkat Ali after a podcast host casually noted taking it. That single mention turned an obscure African shrub into a mass-market supplement almost overnight. The honest problem is that the hype badly outruns the science. Where Tongkat Ali at least has small human trials, Fadogia has essentially none — and the animal data everyone cites for the upside is the same animal data that documents the downside. Here is what the evidence actually shows, and why the safety question is the most important part of this page.
What is Fadogia Agrestis?
Fadogia Agrestis (recently reclassified as Vangueria agrestis) is a flowering shrub native to West Africa, particularly Nigeria, where the stem has a traditional reputation as an aphrodisiac.[1] Modern supplements sell a dried stem extract, typically capsules standardized loosely (if at all) to alkaloid or saponin content. Its constituents include monoterpene glycosides and other phenolic compounds, some of which have been catalogued specifically because analysts wanted to know what is actually in the commercial dietary supplements now on the market.[5] The proposed mechanism is a rise in testosterone, possibly by acting on the enzymes and signaling that drive the testes’ own production — but that mechanism, like everything else here, was worked out in rodents.
0
Published randomized human trials of Fadogia Agrestis
PubMed, 2026
Rats only
Species in every efficacy study behind the testosterone claim
Yakubu et al.
18–100 mg/kg
Dose range in the rat studies — including the doses that caused toxicity
J Ethnopharmacol 2008
Does Fadogia Agrestis actually raise testosterone?
In rats, yes — and that is the whole evidence base. In the foundational study, aqueous extract of Fadogia stem (18, 50 and 100 mg/kg for five days) produced a dose-dependent rise in serum testosterone in male rats, alongside increased mounting and intromission frequency and other markers of sexual behavior — a genuine, internally consistent aphrodisiac signal in the animal.[1] A more recent rat study found that Fadogia stem extract helped restore erectile-function biomolecules in the testicular and penile tissue of rats whose sexual function had been suppressed by paroxetine.[4] So the pro-androgen, pro-libido effect is real — in rodents.
The gap you cannot wave away: none of this has been tested in humans. There is no published human trial showing Fadogia raises testosterone in men, no dose-finding study, and no data on whether a rat’s response at 18–100 mg/kg translates to anything in a person. Animal hormone data is a starting hypothesis, not evidence of a human benefit — the history of supplements is littered with compounds that moved a biomarker in rats and did nothing (or worse) in people. When a product’s entire efficacy claim rests on rodents, the honest label is preclinical, not “proven testosterone booster.”
The part the marketing buries: the toxicity signal
This is the most important section on the page, because the very studies used to sell Fadogia are also the ones that flag it. When rats were given the extract daily for 28 days rather than a few days, the higher doses produced adverse changes in testicular function — altered testicular enzyme markers and an increased testes-to-body-weight ratio consistent with testicular damage, not enhancement.[2] The irony is sharp: the same herb marketed to boost the testes appeared to harm them with sustained use. Only the lowest dose (18 mg/kg) showed signs of recovery, which the authors read as toxicity that was dose-dependent rather than absent.
The damage was not limited to the testes. A separate study examining the mode of cellular toxicity of the aqueous stem extract reported evidence of injury in the liver and kidney of male rats — the extract disrupted markers of organ integrity, indicating the compound is not benign at the doses that produce its hormonal effects.[3] Put together, the preclinical picture is a narrow window: the doses that raise testosterone in rats sit uncomfortably close to the doses that damage organs in rats, and nobody has mapped where — or whether — that window exists in humans.
| Claim | What the evidence is | The honest caveat |
|---|---|---|
| Raises testosterone | Dose-dependent rise in serum testosterone in rats | Rodents only; no human trial of any kind |
| Boosts libido / sexual function | Increased mating behavior in rats; ED-marker recovery in rats | Animal behavior; never tested in men |
| Safe to take daily | No — 28-day rat dosing showed testicular damage | Toxicity is documented, not theoretical |
| Protects the testes | Opposite signal: testicular injury at higher doses | The herb marketed for the testes harmed them in rats |
| Established dose exists | No — rat doses were 18–100 mg/kg | Human '600 mg/day' figure is unstudied lore |
Dose and “cycling”: honestly, nobody knows
Because there are no human trials, there is no evidence-based human dose. The figures passed around online — commonly 300–600 mg/day of stem extract, cycled a few weeks on and off — are pure community convention, not something any study established. The “cycling” habit is often justified by a vague worry about the toxicity data, which is telling: the practice exists precisely because people sense the compound may not be safe to take continuously, yet nobody can say what schedule (if any) actually mitigates the organ-toxicity signal seen in rats.[2][3] Extract potency also varies between products, so even the community dose is being measured against an unknown quantity of active compound.[5] The intellectually honest answer to “how much should I take?” is: there is no dose known to be both effective and safe in humans.
The Tongkat Ali stack: one has human data, one doesn’t
Fadogia is almost always sold and taken with Tongkat Ali, and the pairing is worth pulling apart because the two are not on equal evidence footing. Tongkat Ali has a small but real set of human randomized trials — modest testosterone rises, lower cortisol, some libido signal — and a reasonable tolerability record at studied doses. Fadogia contributes the rat-only half of the stack and the toxicity flag. When people report the combination “works,” the component with actual human evidence behind it is Tongkat Ali; Fadogia is riding along as the unproven, higher-risk addition. If you were going to try one, the one with human data is the defensible choice — and stacking an animal-only compound with a documented toxicity signal on top of it adds risk without adding evidence.
What to do instead if the goal is real testosterone results
If the reason Fadogia is tempting is genuine concern about low testosterone — low energy, libido, mood, or a lab value under range — then an animal-only herb with an organ-toxicity flag is the wrong tool. The interventions with real, measured human outcomes are a different category: prescription testosterone replacement therapy is dose-titrated, blood-monitored, and backed by large trials (with its own risks and monitoring requirements a clinician manages). Even among botanicals, the better-supported and better-tolerated option for the stress-and-mood angle is ashwagandha, which has human randomized trials rather than rat studies. The theme across all of them is the same one Fadogia fails: real results come with real data and real monitoring, not with a compound tested only in rodents.
The honest bottom line
Fadogia Agrestis is a podcast-made supplement with a genuinely thin, one-sided evidence base. The fair summary: an aphrodisiac and testosterone effect shown only in rats,[1][4] sitting on top of a real, documented toxicity signal — testicular, liver and kidney damage — in those same rats at higher or prolonged doses,[2][3] with no human trials, no established dose, and no long-term safety data whatsoever. That is not a “promising but early” supplement; it is an animal-only compound carrying a specific harm flag that the marketing conveniently omits. If you want the testosterone results the ads imply, the measured, monitored options are the honest place to start — and if you still choose to experiment with Fadogia, do it with a clinician, at the lowest plausible exposure, and with your eyes open to the fact that the only toxicity data that exists says be careful.